Clinical Trials
4 trialsNCT05119335 2025-11-12
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
NiKang Therapeutics, Inc.
Phase 1/2 Terminated
NCT02449681 2023-01-12
Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin
Rain Oncology Inc
Phase 2 Terminated
NCT02454842 2023-01-12
TH-4000
Rain Oncology Inc
Phase 2 Terminated
NCT01118819 2016-01-20
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Phase 1 Terminated